GESTATIONAL DIABETES MELLITUS: A CASE REPORT WITH A CHARACTER FOCUSED ON THE INDIVIDUALIZATION OF THE PATIENT

• DOI: 10.22533/at.ed.1593172307010

• Palavras-chave: Introduction: Gestational Diabetes Mellitus (GDM) is considered a group of metabolic disorders, which lead to hyperglycemia, manifested by a set of symptoms. GDM affects the maternal-fetal binomial, reverberating as a major problem in the Unified Health System (SUS), as it is considered a high-risk pathology. Case Presentation: female cisgender patient, 42 years old, fourth pregnancy, with previous systemic arterial hypertension, started prenatal care at 10 weeks of gestational age. Classified in the Body Mass Index (BMI) as overweight. During the prenatal period, her exams presented sufficient alterations for the diagnosis of GDM. From a biopsychosocial context, drug treatment with Metformin was performed. During and after delivery, the mother and baby did not experience any intercurrences. Conclusions: in view of the case, the patient underwent prenatal care according to the guidelines, being accompanied by a doctor and a nurse from the family health strategy program, an endocrinologist and a nutritionist. The patient started out overweight and progressed to obesity, as the pregnancy progressed, so non-pharmacological aspects were not enough to prevent GDM. Their biopsychosocial aspects were respected, which enabled the use of the oral hypoglycemic agent, metformin. Therefore, there were no complications during the gestational period, nor during labor and postpartum.

• Keywords: Introduction: Gestational Diabetes Mellitus (GDM) is considered a group of metabolic disorders, which lead to hyperglycemia, manifested by a set of symptoms. GDM affects the maternal-fetal binomial, reverberating as a major problem in the Unified Health System (SUS), as it is considered a high-risk pathology. Case Presentation: female cisgender patient, 42 years old, fourth pregnancy, with previous systemic arterial hypertension, started prenatal care at 10 weeks of gestational age. Classified in the Body Mass Index (BMI) as overweight. During the prenatal period, her exams presented sufficient alterations for the diagnosis of GDM. From a biopsychosocial context, drug treatment with Metformin was performed. During and after delivery, the mother and baby did not experience any intercurrences. Conclusions: in view of the case, the patient underwent prenatal care according to the guidelines, being accompanied by a doctor and a nurse from the family health strategy program, an endocrinologist and a nutritionist. The patient started out overweight and progressed to obesity, as the pregnancy progressed, so non-pharmacological aspects were not enough to prevent GDM. Their biopsychosocial aspects were respected, which enabled the use of the oral hypoglycemic agent, metformin. Therefore, there were no complications during the gestational period, nor during labor and postpartum.

• Abstract:

  Introduction: Gestational Diabetes Mellitus (GDM) is considered a group of metabolic disorders, which lead to hyperglycemia, manifested by a set of symptoms. GDM affects the maternal-fetal binomial, reverberating as a major problem in the Unified Health System (SUS), as it is considered a high-risk pathology. Case Presentation: female cisgender patient, 42 years old, fourth pregnancy, with previous systemic arterial hypertension, started prenatal care at 10 weeks of gestational age. Classified in the Body Mass Index (BMI) as overweight. During the prenatal period, her exams presented sufficient alterations for the diagnosis of GDM. From a biopsychosocial context, drug treatment with Metformin was performed. During and after delivery, the mother and baby did not experience any intercurrences. Conclusions: in view of the case, the patient underwent prenatal care according to the guidelines, being accompanied by a doctor and a nurse from the family health strategy program, an endocrinologist and a nutritionist. The patient started out overweight and progressed to obesity, as the pregnancy progressed, so non-pharmacological aspects were not enough to prevent GDM. Their biopsychosocial aspects were respected, which enabled the use of the oral hypoglycemic agent, metformin. Therefore, there were no complications during the gestational period, nor during labor and postpartum.